Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jennifer K Goy"'
Autor:
Donald M. Arnold, Jennifer K Goy, Geoffrey R. Norman, George R. Buchanan, Cindy E. Neunert, Nastaran Noroozi, Ishac Nazi, John G. Kelton
Publikováno v:
Journal of Thrombosis and Haemostasis. 13:457-464
The burden of severe bleeding in adults and children with immune thrombocytopenia (ITP) has not been established.To describe the frequency and severity of bleeding events in patients with ITP, and the methods used to measure bleeding in ITP studies.W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d7a0f6cc28515b9003f7a67b0e9768
https://doi.org/10.1111/jth.12813
https://doi.org/10.1111/jth.12813
Autor:
Jennifer K Goy, Matthew Miller, John G. Kelton, Nastaran Noroozi, Grace Wang, Siraj Mithoowani, Kathleen Gregory-Miller, Donald M. Arnold
Publikováno v:
The Lancet. Haematology. 3(10)
Summary Background Whether high-dose dexamethasone has long-term efficacy and safety in previously untreated patients with immune thrombocytopenia is unclear. We did a systematic review and a meta-analysis of randomised trials to establish the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee3b86125d6101922e346e69026199b
https://pubmed.ncbi.nlm.nih.gov/27658982
https://pubmed.ncbi.nlm.nih.gov/27658982
Autor:
Jennifer K Goy, Mark Crowther
Publikováno v:
Seminars in Thrombosis and Hemostasis. 38:702-710
Anticoagulant therapy reduces deaths and disability in patients with or at risk of both arterial and venous thromboembolism. Highly effective antithrombotic therapies now exist that reduce the risk of both arterial thrombosis and venous thrombosis. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a2f1318bd37da508c718963c655b32
https://doi.org/10.1055/s-0032-1326788
https://doi.org/10.1055/s-0032-1326788
Autor:
Mohammad Almutawa, Susan Nahirniak, Jennifer K Goy, Bruce Ritchie, Sam Schulman, Shari Ghanny
Publikováno v:
British Journal of Haematology. 164:308-310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7348d4925553bff517825a4db09c82bb
https://doi.org/10.1111/bjh.12620
https://doi.org/10.1111/bjh.12620
Publikováno v:
Thrombosis research. 134(5)
Abstract 3334 Rofecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor, has been associated with increased arterial thrombosis. It is unknown whether it is associated with venous thromboembolism (VTE). We investigated, using a systematic review of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e7aba0bbdaf942b9846a9bbeb7091a
https://pubmed.ncbi.nlm.nih.gov/25246044
https://pubmed.ncbi.nlm.nih.gov/25246044
Autor:
Jennifer K Goy, Cindy E. Neunert, Donald M. Arnold, George R. Buchanan, Victor S. Blanchette, Nastaran Noroozi
Publikováno v:
Blood. 120:4281-4281
Abstract 4281 Background: Bleeding is arguably the most clinically meaningful outcome in ITP clinical studies since it impacts morbidity, mortality and quality of life. Yet, the measurement of bleeding is not standardized, and its prevalence as a stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9cce38d2927aaa24164ef8f5713b855
https://doi.org/10.1182/blood.v120.21.4281.4281
https://doi.org/10.1182/blood.v120.21.4281.4281